Molecular analysis of measles virus genome derived from SSPE and acute measles patients in Papua, New Guinea

2002 ◽  
Vol 68 (1) ◽  
pp. 105-112 ◽  
Author(s):  
Kenji Miki ◽  
Katsuhiro Komase ◽  
Charles S. Mgone ◽  
Ryuta Kawanishi ◽  
Masumi Iijima ◽  
...  
Keyword(s):  
Papua New Guinea ◽  
Molecular Analysis ◽  
Measles Virus ◽  
New Guinea ◽  
Virus Genome

scholarly journals Molecular analysis of microbial communities in mobile deltaic muds of Southeastern Papua New Guinea

2000 ◽  
Vol 33 (2) ◽  
pp. 147-155 ◽  
Author(s):  
Julia R. Todorov ◽  
Andrei Y. Chistoserdov ◽  
Josephine Y. Aller
Keyword(s):  
Microbial Communities ◽  
Papua New Guinea ◽  
Molecular Analysis ◽  
New Guinea

scholarly journals A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea

2003 ◽  
Vol 131 (2) ◽  
pp. 887-898 ◽  
Author(s):  
T. TAKASU ◽  
J. M. MGONE ◽  
C. S. MGONE ◽  
K. MIKI ◽  
K. KOMASE ◽  
...  
Keyword(s):  
Papua New Guinea ◽  
Measles Virus ◽  
Age Of Onset ◽  
Subacute Sclerosing Panencephalitis ◽  
New Guinea ◽  
High Incidence ◽  
Antibody Titres ◽  
History Of ◽  
Measles Vaccination ◽  
Eastern Highlands

The aims of this descriptive study were to confirm the high incidence of subacute sclerosing panencephalitis (SSPE) previously reported from Papua New Guinea (PNG) and to relate SSPE to previous measles vaccination and measles illness. From February 1997 to April 1999 we diagnosed a total of 55 patients with SSPE at Goroka Base General Hospital in Eastern Highlands Province (EHP) of PNG. The diagnosis was based on high cerebrospinal fluid and serum measles virus antibody titres with progressive neurological disorder and myoclonic jerks. Of these 55 patients 42 were from EHP, including 32 whose onset was in the 2-year period 1997–1998. The annual incidence of SSPE in EHP in these 2 years was 98 per million population under 20 years of age, the highest ever reported. This incidence was more than ten times higher than the highest incidence in the prevaccine era reported from elsewhere. The mean age of onset of SSPE was 7·7 years (range 2·8–14·8 years) and the interval between measles and the onset of SSPE, where known, had a mean of 5·9 years and a range of 2·5–11·1 years. Among the SSPE patients 19 had a documented history of measles vaccination. Eight of these 19 also had documentation of previous measles illness; of these, seven were vaccinated after the development of measles and one was vaccinated 20 days before measles illness. Two non-SSPE children received vaccination twice which was documented and subsequently developed measles which was also substantiated by documentation. Two patients with SSPE yielded amplified nucleotide sequences of measles virus that were different from any of the vaccine strains. We found no evidence to implicate measles vaccination in the development of SSPE.

MOLECULAR ANALYSIS OF PLASMODIUM FALCIPARUM FROM DRUG TREATMENT FAILURE PATIENTS IN PAPUA NEW GUINEA

2004 ◽  
Vol 70 (3) ◽  
pp. 251-255 ◽  
Author(s):  
GERARD J. CASEY ◽  
BLAISE GENTON ◽  
JOHN C. REEDER ◽  
MEZA GINNY ◽  
ALAN F. COWMAN ◽  
...  
Keyword(s):  
Plasmodium Falciparum ◽  
Drug Treatment ◽  
Treatment Failure ◽  
Papua New Guinea ◽  
Molecular Analysis ◽  
New Guinea

Public Health in Papua New Guinea

1989 ◽  
Author(s):  
Donald Denoon ◽  
Kathleen Dugan ◽  
Leslie Marshall
Keyword(s):  
Public Health ◽  
Papua New Guinea ◽  
New Guinea

Papua New Guinea: Searching for a Fit Between Child, Culture, and School

1984 ◽  
Vol 29 (10) ◽  
pp. 786-788
Author(s):  
Patricia M. Greenfield
Keyword(s):  
Papua New Guinea ◽  
New Guinea ◽  
Child Culture

Going Native? Test Development and Adaptation for Papua New Guinea

2012 ◽  
Author(s):  
Esteban Tristan ◽  
Mei-Chuan Kung ◽  
Peter Caccamo
Keyword(s):  
Papua New Guinea ◽  
Test Development ◽  
New Guinea ◽  
Going Native
Sign in / Sign up

Export Citation Format

Share Document